DR. ALBERT JOHN ALLEN, M.D.
Psychiatric in Indianapolis, IN

License number
Indiana 036.091865
Category
Psychiatric
Type
Psychiatry
License number
Indiana 036.091865
Category
Psychiatric
Type
Child & Adolescent Psychiatry
Address
Address
Eli Lilly And Company Lilly Corporate Ctr, Indianapolis, IN 46285
Phone
(317) 277-6242

Personal information

See more information about ALBERT JOHN ALLEN at radaris.com
Name
Address
Phone
Albert Allen
351 N Allen Chapel Rd, Kendallville, IN 46755

Professional information

Albert John Allen Photo 1

Albert John Allen, Indianapolis IN

Specialties:
Child and Adolescent Psychiatrist
Address:
Eli Lilly And Company, Indianapolis, IN 46285


Albert Allen Photo 2

Treatment Of Pervasive Developemental Disorders With Norepinephrine Reuptake Inhibitors

US Patent:
2006024, Oct 26, 2006
Filed:
Aug 25, 2004
Appl. No.:
10/568466
Inventors:
Albert Allen - Indianapolis IN, US
Douglas Kelsey - Zionsville IN, US
Assignee:
ELILILLY AND COMPANY - Indianapolis IN
International Classification:
A61K 31/138
US Classification:
514651000
Abstract:
Provided are methods and medicaments for treating a Pervasive Developmental Disorder, comprising administering to a patient in need of such treatment an effective amount of a selective norepinephrine reuptake inhibitor.


Albert Allen Photo 3

Treatment Of Hot Flashes, Impulse Control Disorders And Personality Change Due To A General Medical Condition

US Patent:
2007001, Jan 18, 2007
Filed:
Dec 1, 2004
Appl. No.:
10/581015
Inventors:
Albert Allen - Indianapolis IN, US
Calvin Sumner - Lebanon IN, US
Owen Wallace - Zionsville IN, US
Assignee:
Eli Lily and Company - Indianapolis IN
International Classification:
A61K 31/138
US Classification:
514300000, 514651000
Abstract:
Selective norepinephrine reuptake inhibitors are useful for the prevention or treatment of hot flashes, vasomotor symptoms, impulse control disorders or personality change due to a general medical condition.


Albert Allen Photo 4

Use Of Norepinephrine Reuptake Inhibitors For The Treatment Of Tic Disorders

US Patent:
2008020, Aug 21, 2008
Filed:
Apr 1, 2008
Appl. No.:
12/060318
Inventors:
Albert John Allen - Indianapolis IN, US
David Michelson - Carmel IN, US
International Classification:
A61K 31/135, A61P 25/00
US Classification:
514651
Abstract:
Selective norepinephrine reuptake inhibitors are used to treat tic disorders.


Albert Allen Photo 5

Combination Therapy For The Treatment Of Neurological Disorders

US Patent:
2004017, Sep 9, 2004
Filed:
Jan 22, 2004
Appl. No.:
10/484646
Inventors:
Albert Allen - Indianapolis IN, US
David Michelson - Carmel IN, US
John-Michael Sauer - Indianapolis IN, US
International Classification:
A61K031/445, A61K031/137
US Classification:
514/649000, 514/277000
Abstract:
The invention provides improved formulations and methods for the treatment of neurological disorders.


Albert Allen Photo 6

Use Of Norepinephrine Reuptake Inhibitors For The Treatment Of Tic Disorders

US Patent:
2005001, Jan 20, 2005
Filed:
Nov 12, 2002
Appl. No.:
10/495303
Inventors:
Albert Allen - Indianapolis IN, US
David Michelson - Carmel IN, US
International Classification:
A61K031/135
US Classification:
514646000, 514579000
Abstract:
Selective norepinephrine reuptake inhibitors are used to treat tic disorders.